Article Text

Download PDFPDF
CASE REPORT
Blue toe syndrome as a first sign of systemic sclerosis
  1. Rugina Neuman,
  2. Marike Wabbijn,
  3. Samara Guillen,
  4. Adriaan Dees
  1. Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands
  1. Correspondence to Dr Adriaan Dees, ADees{at}planet.nl

Summary

We describe an unusual case of blue toe syndrome as the primary and solitary manifestation of systemic sclerosis. The possible cause was long-term occupational exposure in construction work. Blue toe syndrome is a small vessel disease, characterised by the sudden development of painful, blue discolouration in one or more toes. The most common aetiology is atheroembolic disease; however, it can also appear in several conditions ranging from hypercoagulability disorders to underlying systemic diseases such as vasculitis or autoimmune diseases. Here, we describe the case of a 57-year-old man who presented with blue toe syndrome without underlying atheroembolic disease. He was found to have positive anticentromere antibodies, which indicated that systemic sclerosis was the likely primary underlying cause. An extensive systemic evaluation and a thorough physical examination revealed no other symptoms associated with systemic sclerosis. He was prescribed nifedipin and rosuvastatin, and showed complete resolution of symptoms after 3 months.

  • vascular surgery
  • vasculitis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All authors (RN, MW, SG, AD) participated in the preparation of the manuscript and the revised version as well. The literature survey was performed by SG. RN wrote the initial version. RN and AD wrote the final version. MW and AD treated and followed the patient in the outpatient clinic.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.